JP2015522049A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015522049A5 JP2015522049A5 JP2015520915A JP2015520915A JP2015522049A5 JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5 JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- formulation
- amount
- alcohol
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12176115 | 2012-07-12 | ||
| EP12176115.9 | 2012-07-12 | ||
| PCT/EP2013/064123 WO2014009241A1 (en) | 2012-07-12 | 2013-07-04 | Diclofenac formulations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017182383A Division JP6434104B2 (ja) | 2012-07-12 | 2017-09-22 | ジクロフェナク製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015522049A JP2015522049A (ja) | 2015-08-03 |
| JP2015522049A5 true JP2015522049A5 (enExample) | 2016-06-16 |
| JP6259454B2 JP6259454B2 (ja) | 2018-01-10 |
Family
ID=48741196
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015520915A Active JP6259454B2 (ja) | 2012-07-12 | 2013-07-04 | ジクロフェナク製剤 |
| JP2017182383A Active JP6434104B2 (ja) | 2012-07-12 | 2017-09-22 | ジクロフェナク製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017182383A Active JP6434104B2 (ja) | 2012-07-12 | 2017-09-22 | ジクロフェナク製剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9999590B2 (enExample) |
| EP (2) | EP3275466A1 (enExample) |
| JP (2) | JP6259454B2 (enExample) |
| KR (1) | KR20150030752A (enExample) |
| CN (1) | CN104428003B (enExample) |
| AU (1) | AU2013289403B2 (enExample) |
| BR (1) | BR112015000329A2 (enExample) |
| CA (1) | CA2878784A1 (enExample) |
| HK (1) | HK1204973A1 (enExample) |
| IL (1) | IL236304A0 (enExample) |
| MX (1) | MX2015000541A (enExample) |
| NZ (1) | NZ702967A (enExample) |
| RU (1) | RU2014152445A (enExample) |
| WO (1) | WO2014009241A1 (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10813897B2 (en) * | 2011-12-27 | 2020-10-27 | Cmpd Licensing, Llc | Composition and method for compounded therapy |
| EP3275466A1 (en) * | 2012-07-12 | 2018-01-31 | Ferring B.V. | Diclofenac formulations |
| US9855234B2 (en) * | 2014-07-08 | 2018-01-02 | Insys Development Company, Inc. | Diclofenac sublingual spray |
| US11020356B2 (en) | 2016-12-28 | 2021-06-01 | Hisamitsu Pharmaceutical Co., Inc. | Drug-containing patch |
| JP7109093B2 (ja) * | 2017-01-31 | 2022-07-29 | 帝國製薬株式会社 | リドカインおよびジクロフェナクを含む医薬用貼付剤についての投与計画 |
| US20210137829A1 (en) * | 2017-03-07 | 2021-05-13 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Topical delivery systems for active compounds |
| KR20190101140A (ko) * | 2018-02-22 | 2019-08-30 | 동아제약 주식회사 | 비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물 |
| JP7053790B2 (ja) | 2018-02-27 | 2022-04-12 | 久光製薬株式会社 | ジクロフェナク含有乳化ゲル組成物 |
| EP3927320A2 (en) * | 2019-02-19 | 2021-12-29 | Bluepharma Indústria Farmacêutica, S.A. | Mucoadhesive compositions and uses thereof |
| JP6761553B1 (ja) * | 2020-02-12 | 2020-09-23 | 久光製薬株式会社 | ジクロフェナクナトリウム含有貼付剤 |
| JP6744512B1 (ja) * | 2020-02-12 | 2020-08-19 | 久光製薬株式会社 | ジクロフェナクナトリウム含有貼付剤 |
| US20230157979A1 (en) * | 2020-02-27 | 2023-05-25 | Ferring B.V. | Topical diclofenac compositions and methods |
| JP2022096994A (ja) * | 2020-12-18 | 2022-06-30 | 小林製薬株式会社 | 外用医薬組成物 |
| US11872320B2 (en) | 2021-02-25 | 2024-01-16 | Hisamitsu Pharmaceutical Co., Inc. | Method for treating osteoarthritis |
| IT202100016751A1 (it) | 2021-06-25 | 2022-12-25 | Altergon Sa | Formulazione topica di diclofenac ad elevato tasso di assorbimento |
| WO2023052599A1 (en) | 2021-10-01 | 2023-04-06 | Nutrition & Biosciences Usa 1, Llc | Hydrocolloid blend compositions for topical application |
| EP4223280A1 (en) * | 2022-02-02 | 2023-08-09 | GSK Consumer Healthcare SARL | Diclofenac formulations |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9803871D0 (sv) | 1998-11-11 | 1998-11-11 | Pharmacia & Upjohn Ab | Therapeutic method and formulation |
| WO2005039531A1 (en) | 2003-10-10 | 2005-05-06 | Antares Pharma Ipl Ag | Transdermal pharmaceutical formulation for minimizing skin residues |
| US20070225379A1 (en) * | 2001-08-03 | 2007-09-27 | Carrara Dario Norberto R | Transdermal delivery of systemically active central nervous system drugs |
| US6509040B1 (en) | 2001-06-22 | 2003-01-21 | R.P. Scherer Corporation | Fast dispersing dosage forms essentially free of mammalian gelatin |
| MY148466A (en) | 2001-10-26 | 2013-04-30 | Merck Frosst Canada Ltd | Granule formulation |
| GB0210397D0 (en) | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
| AR041021A1 (es) | 2002-08-22 | 2005-04-27 | Novartis Consumer Health Sa | Composicion topica |
| US20040096569A1 (en) | 2002-11-15 | 2004-05-20 | Barkalow David G. | Edible film products and methods of making same |
| EP1428526A1 (en) | 2002-12-13 | 2004-06-16 | Rijksuniversiteit Groningen | Formulation for fast dissolution of lipophilic compounds |
| US8158152B2 (en) | 2005-11-18 | 2012-04-17 | Scidose Llc | Lyophilization process and products obtained thereby |
| GB0524958D0 (en) | 2005-12-07 | 2006-01-18 | Pharmakodex Ltd | Transdermal administration of active agents |
| DK2347775T3 (da) | 2005-12-13 | 2020-07-13 | Harvard College | Skabeloner til celletransplantation |
| TW200815045A (en) | 2006-06-29 | 2008-04-01 | Jazz Pharmaceuticals Inc | Pharmaceutical compositions of ropinirole and methods of use thereof |
| EP2055298A1 (en) | 2007-10-30 | 2009-05-06 | Novartis AG | Topical composition |
| US8623401B2 (en) | 2008-03-27 | 2014-01-07 | Fenwafe Inc. | Wafer formulation |
| WO2010060798A1 (en) | 2008-11-28 | 2010-06-03 | Advance Holdings Limited | Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester |
| WO2010103845A1 (ja) | 2009-03-11 | 2010-09-16 | 興和株式会社 | 鎮痛・抗炎症剤含有外用剤 |
| MX341200B (es) | 2010-03-29 | 2016-08-11 | Ferring Bv | Composicion farmaceutica de disolucion rapida. |
| EP3275466A1 (en) * | 2012-07-12 | 2018-01-31 | Ferring B.V. | Diclofenac formulations |
-
2013
- 2013-07-04 EP EP17190099.6A patent/EP3275466A1/en not_active Withdrawn
- 2013-07-04 HK HK15105792.2A patent/HK1204973A1/xx unknown
- 2013-07-04 CN CN201380036305.1A patent/CN104428003B/zh active Active
- 2013-07-04 RU RU2014152445A patent/RU2014152445A/ru not_active Application Discontinuation
- 2013-07-04 EP EP13733003.1A patent/EP2872177B1/en not_active Not-in-force
- 2013-07-04 AU AU2013289403A patent/AU2013289403B2/en not_active Ceased
- 2013-07-04 BR BR112015000329A patent/BR112015000329A2/pt active Search and Examination
- 2013-07-04 US US14/413,922 patent/US9999590B2/en active Active
- 2013-07-04 JP JP2015520915A patent/JP6259454B2/ja active Active
- 2013-07-04 NZ NZ702967A patent/NZ702967A/en not_active IP Right Cessation
- 2013-07-04 CA CA2878784A patent/CA2878784A1/en not_active Abandoned
- 2013-07-04 MX MX2015000541A patent/MX2015000541A/es unknown
- 2013-07-04 KR KR20157003028A patent/KR20150030752A/ko not_active Withdrawn
- 2013-07-04 WO PCT/EP2013/064123 patent/WO2014009241A1/en not_active Ceased
-
2014
- 2014-12-16 IL IL236304A patent/IL236304A0/en unknown
-
2017
- 2017-09-22 JP JP2017182383A patent/JP6434104B2/ja active Active
-
2018
- 2018-05-18 US US15/983,911 patent/US10117829B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2014152445A (ru) | Композиции на основе диклофенака | |
| AU2013359392C1 (en) | Compositions and methods for tissue regeneration | |
| JP2014503565A5 (enExample) | ||
| WO2009053741A3 (en) | Novel formulation | |
| JP2014530242A5 (enExample) | ||
| RU2013133082A (ru) | Композиции тестостерона | |
| ECSP045140A (es) | Formulaciones farmacéuticas derivadas del platino | |
| JP2013515002A5 (enExample) | ||
| JP2012517450A5 (enExample) | ||
| EA201590591A1 (ru) | Способ приготовления геля на основе полифенолов гранатовой кожуры для лечения воспалительных заболеваний в гинекологии | |
| US20140094438A1 (en) | Compositions and methods for the treatment of pain | |
| JP2015172093A (ja) | ロキソプロフェン又はその塩含有の医薬組成物そのｉｉ | |
| CA2875052C (en) | Method for treating skin inflammatory diseases | |
| JP2012525358A5 (enExample) | ||
| JP2016106138A (ja) | ロキソプロフェン又はその塩含有の医薬組成物＜２＞ | |
| CN101433544B (zh) | 具有抗炎消肿镇痛作用的外用药物组合物制剂与用途 | |
| WO2016181355A1 (en) | Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity | |
| WO2017129108A1 (zh) | 一种用于治疗皮肤病的硅凝胶 | |
| NZ606177A (en) | Compositions for the treatment of actinic keratosis | |
| RU2016101152A (ru) | Терапевтические агенты для применения в профилактике и/или лечении гиперкинетических двигательных расстройств | |
| TW201622712A (zh) | 外用醫藥組成物 | |
| CN112007039A (zh) | 一种包含氟西汀和维生素d3或其衍生物的组合物，及其应用 | |
| EP2234581A1 (en) | Acetic acid/thymol compositions and their use in the treatment of onychomycosis | |
| JP6477005B2 (ja) | 角層水分量の低下抑制剤 | |
| CN101259138A (zh) | 局部应用于动物运动系统部位的消炎和镇痛组合物 |